Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors, Primitive

Explore clinical trials studying Neuroectodermal Tumors, Primitive. Study availability and eligibility vary by location and protocol.

727 public trials 122 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors, Primitive trial results

Recruiting

Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors

NCT01356290

Conditions
ATRT Recurrent, Disease Attributes, Ependymoma, +16 more
Locations
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Dana-Farber Cancer Institute and Boston Children's Hospital Boston, Massachusetts, United States
  • Helen DeVos Children's Hospital Grand Rapids, Michigan, United States
  • Dell Children's Medical Group SFC-HEM/ONC Austin, Texas, United States
View all 22 locations
View Trial Details
Recruiting

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

NCT05535166

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +14 more
Locations
  • Lucille Packard Children's Hospital Stanford Palo Alto, California, United States
  • Orlando Health Arnold Palmer Hospital for Children Orlando, Florida, United States
  • St. Joseph's Children's Hospital Tampa, Florida, United States
  • C.S. MOTT Children's Hospital, University of Michigan Ann Arbor, Michigan, United States
View Trial Details
Recruiting

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

NCT06831552

Conditions
High-risk Neuroblastoma, Neoplasms, Neoplasms by Histologic Type, +8 more
Locations
  • Connecticut Children's Medical Center Hartford, Connecticut, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

SPEARHEAD-3 Pediatric Study

NCT05642455

Conditions
Fibrosarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Neoplasms, +26 more
Locations
  • Stanford University Palo Alto, California, United States
  • National Institutes of Health Bethesda, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
View Trial Details

Related conditions